Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
Automation can have positive effects in many different areas, such as case intake, duplicate check, follow up, narrative generation, quality check or end-to-end processing. But which one are you most likely to automate?
On November 28, 2017, ArisGlobal held a webinar with DIA, “How Automation Can Deliver the Holy Grail in Safety: Achieve Productivity, Compliance and Quality”. In this webinar, we posed a few questions to the audience, and came up with some interesting information. We took this and spent some thinking about what this means to our clients in the PV ecosystem.
Artificial intelligence (AI), machine learning, deep learning, natural language processing – in short, cognitive computing, is changing the pharmacovigilance world as we know it. While there’s a lot of talk about how AI will affect jobs, where it will have the most powerful impact is on the quality of work and the speed at which manual tasks can be accomplished.
If you are on the front lines of regulatory information ...
Managing and Mastering Pharmacovigilance covers how LifeSphere Multivigilance 10 benefits small to medium-sized businesses by utilizing industry-standard practices and proper management processes.
A key offering in ArisGlobal’s LifeSphere platform, LifeSphere Reporter empowers field reps, provides fields teams and approved users with secure access, and easily integrates with LSMV10 and other systems.
ArisGlobal believes that there is no single “right place to start” when it comes to automation, and life sciences organizations must instead choose their own adventure when it comes to a sound PV-focused automation strategy. Read part two of our three-part blog series.
Christina Johnson, Associate Director Product Management Regulatory at ArisGlobal will be presenting at the Global Pharmaceutical Regulatory Affairs Summit Digital Week, on June 25th, 2020.
A versatile Clinical Trial Management Solution, LifeSphere® CTMS10 contains great functionality and five key benefits, addressing a variety of challenges in the clinical product lifecycle.
This is the last in the ArisGlobal three-part blog series on Regulatory Affairs transformation. Digitization is sweeping the life sciences industry, disrupting traditional working practices and opening doors to better ways of collaborating, tracking and sharing documents and data, and gaining clear oversight into the product supply chain.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved